Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Antitumor effect of secreted Flt3-ligand can act at distant tumor sites in a murine model of head and neck cancer

Cancer Gene Therapy volume 10, pages 96–104 (2003)Cite this article

Abstract

The Flt3 ligand (Flt3-L) manifests antitumor activity, presumably due to its capacity to recruit dendritic cells and cause their proliferation. To assess whether local production of Flt3-L can mediate a “distant bystander” effect, murine B4B8 squamous cell carcinoma cells were transfected with a plasmid encoding a secretory form of Flt3-L to produce B4B8FL cells. Similarly, B4B8FL and B4B8 cells were transfected with herpes simplex virus thymidine kinase (HSVTK) to produce B4B8TK and B4B8FL/TK cells, which should be sensitive to ganciclovir (GCV), to know whether the effects of Flt3-L and HSVTK/GCV would be synergistic. To test for a distant bystander effect in vivo, B4B8FL, B4B8TK, and B4B8FL/TK cells were injected subcutaneously into the left flank of syngeneic Balb/c mice, and naïve B4B8 cells were injected into the right flank. The formation of tumors derived from B4B8FL and B4B8FL/TK cells was significantly delayed in both flanks compared with naïve B4B8 and B4B8TK cells. Growth of B4B8TK tumors in the ipsilateral flank was retarded following GCV treatment, but in contrast to B4B8FL and B4B8FL/TK cells, no distant bystander effect in the contralateral flank was observed. Immunohistochemistry showed lymphocytic infiltrates in both flanks of the B4B8FL and B4B8FL/TK groups. The data indicate that in these cells, local secretion of Flt3-L is sufficient to evoke a distant bystander effect but that expression of HSVTK, even after GCV administration, is not. Furthermore, the combination of local Flt3-L and HSVTK production, together with GCV administration, does not enhance the distant bystander effect produced by Flt3-L alone.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  1. Fearon E, Pardoll D, Itaya T, et al. Interleukin-2 production by tumor cells bypasses T helper function in the generation of an anti-tumor response. Cell. 1990;60:397–403.

    Article  CAS  PubMed  Google Scholar 

  2. Armstrong CA, Botella R, Galloway TH, et al. Anti-tumor effects of granulocyte–macrophage colony-stimulating factor production by melanoma cells. Cancer Res. 1996;56:2191–2198.

    CAS  PubMed  Google Scholar 

  3. Chen SH, Chen XHL, Wang Y, et al. Combination gene therapy for liver metastasis of colon carcinoma in vivo. Proc Natl Acad Sci. 1995;92:2577–2581.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Seong JY, Dae SH, Jung OK, et al. Synergistic anti-tumor effects with co-expression of GM-CSF and IFN-r in murine tumors. Int J Cancer. 1998;77:907–912.

    Article  Google Scholar 

  5. Goolee S, Heo DS, Yoon SJ, et al. Effect of GM-CSF and IL-2 coexpression on the anti-tumor immune response. Anticancer Res. 2000;20:2681–2686.

    Google Scholar 

  6. Felzmann T, Ramsey WJ, Blaese RM . Characterization of the anti-tumor immune response generated by treatment of murine tumor with recombinant adenoviruses expressing HSVtk, IL-2, IL-6 or B7-1. Gene Ther. 1997;4:1322–1329.

    Article  CAS  PubMed  Google Scholar 

  7. Allione A, Consalvo M, Nanni P, et al. Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin IL-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte–macrophage colony-stimulating factor, and gamma interferon gene or admixed with conventional adjuvants. Cancer Res. 1994;54:6022–6026.

    CAS  PubMed  Google Scholar 

  8. Cheng YC, Grill SP, Dutschman GE, et al. Metabolism of 9-(1,3-dihydroxy-2-2 propoxymethyl) guanine, a new anti-herpes virus compound in herpes simplex virus–infected cells. J Biol Chem. 1983;258:12460–12464.

    CAS  PubMed  Google Scholar 

  9. Bi WL, Parysek LM, Warnick R, et al. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSVtk retroviral gene therapy. Hum Gene Ther. 1993;4:725–731.

    Article  CAS  PubMed  Google Scholar 

  10. Freeman SM, Abboud CN, Whartenby KA, et al. The “bystander effect”: tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 1993;53:5274–5283.

    CAS  PubMed  Google Scholar 

  11. Elshami AA, Saavedra A, Zhang H, et al. Gap junctions play a role in the “bystander effect” of the herpes simplex virus thymidine kinase/ganciclovir system in vitro. Gene Ther. 1996;3:85–92.

    CAS  PubMed  Google Scholar 

  12. Wygoda MR, Wilson MR, Davis MA, et al. Protection of herpes simplex virus thymidine kinase–transduced cells from ganciclovir-mediated cytotoxicity by bystander cells: the Good Samaritan effect. Cancer Res. 1977;57:1699–1703.

    Google Scholar 

  13. Kim YG, Bi WL, Feliciano ES, et al. Ganciclovir-mediated cell killing and bystander effect is enhanced in cells with two copies of the herpes simplex virus thymidine kinase gene. Cancer Gene Ther. 2000;7:240–246.

    Article  CAS  PubMed  Google Scholar 

  14. Lyman SD, James L, Johnson L, et al. Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells. Blood. 1994;83:2795–2801.

    CAS  PubMed  Google Scholar 

  15. Hannum C, Culpepper J, Campbell D, et al. Ligand for flt4/flk2 receptor regulates growth of haematopoietic stem cells and is encoded by variant RNAs. Nature. 1994;368:643–648.

    Article  CAS  PubMed  Google Scholar 

  16. Lyman SD, Brasel K, Escobar SS, et al. Identification of a soluble and membrane bound isoforms of the murine flt3 ligand generated by alternative splicing of mRNAs. Oncogene. 1995;10:149–159.

    CAS  PubMed  Google Scholar 

  17. Maraskovsky E, Brasel K, Teepe M, et al. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J Exp Med. 1996;184:1953–1962.

    Article  CAS  PubMed  Google Scholar 

  18. Steptoe RJ, Fu F, Li W, et al. Augmentation of dendritic cells in murine organ donors by Flt3 ligand alters the balance between transplant tolerance and immunity. J Immun. 1997;159:5438–5491.

    Google Scholar 

  19. Chen K, Braun S, Lyman S, et al. Anti-tumor activity and immunotherapeutic properties of Flt3-ligand in a murine breast cancer model. Cancer Res. 1997;57:3511–3516.

    CAS  PubMed  Google Scholar 

  20. Lynch DH, Andreasen A, Maraskovsky C, et al. Flt3 ligand induces tumor regression and anti-tumor immune response in vivo. Nat Med. 1997;3:625–631.

    Article  CAS  PubMed  Google Scholar 

  21. Esche C, Subbotin VM, Maliszewski C, et al. Flt3-ligand administration inhibit tumor regression growth in murine melanoma and lymphoma. Cancer Res. 1998;58:380–383.

    CAS  PubMed  Google Scholar 

  22. American Cancer Society. Facts and Figures. Washington, DC: American Cancer Society; 2000.

  23. Landis SH, Murray T, Bolden S, et al. Cancer statistics. Cancer J Clin. 1998;1:6–29.

    Article  Google Scholar 

  24. Day KV, Li D, Liu S, et al. Granulocyte–macrophage colony-stimulating factor in a combination gene therapy strategy for head and neck cancer. Laryngoscope. 2001;111:801–806.

    Article  CAS  PubMed  Google Scholar 

  25. O'Malley BW, Chen SH, Schwartz MR, et al. Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model. Cancer Res. 1995;55:1080–1085.

    CAS  PubMed  Google Scholar 

  26. Bi WL, Kim YG, Feliciano ES, et al. An HSVtk-mediated local and distant anti-tumor bystander effect in tumors of head and neck origin in athymic mice. Cancer Gene Ther. 1997;4:246–252.

    CAS  PubMed  Google Scholar 

  27. Culver KW, Ram Z, Wallbridge S, et al. In vivo gene transfer with retroviral vector–producer cells for treatment of experimental brain tumors. Science (Washington, DC). 1992;256:1550–1552.

    Article  CAS  Google Scholar 

  28. Ram Z, Culver KW, Walbridge S, et al. In situ retroviral-mediated gene transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration. Gene Ther. 1993;53:83–88.

    CAS  Google Scholar 

  29. Kianmanesh AR, Perrin H, Panis Y, et al. A “Distant” bystander effect of suicide gene therapy regression of nontransduced tumor together with a distance transduced tumor. Hum Gene Ther. 1997;8:1807–1814.

    Article  CAS  PubMed  Google Scholar 

  30. Agard C, Ligeza C, Dupas B, et al. Immune-dependent distant bystander effect after adenovirus-mediated suicide gene transfer in a rat model of liver colorectal metastasis. Cancer Gene Ther. 2001;8:128–136.

    Article  CAS  PubMed  Google Scholar 

  31. Wilson KM, Stambrook PJ, Bi WL, et al. HSV-tk gene therapy in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 1996;122:746–749.

    Article  CAS  PubMed  Google Scholar 

  32. Lyman SD, Brasel K, Rousseau AM, et al. The flt3 ligand: a hematopoietic stem cell factor whose activities are distinct from steel factor. Stem Cells. 1994;12:99–107.

    PubMed  Google Scholar 

  33. Small D, Levenseein M, Kim E, et al. The human homolog of flt2.flt3, is selectively expressed in CD34 human bone marrow cells and is involved in proliferation of early progenitory stem cells. Proc Natl Acad Sci. 1994;91:459–463.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Rosenet O, Schiff C, Pebusque MJ, et al. Human filt3/flt2 gene: cDNA cloning and expression in hematopoietic cells. Blood. 1993;82:1110–1119.

    Google Scholar 

  35. Qiao J, Blacb ME, Caruso M . Enhanced ganciclovir killing and bystander effect of human tumor cells transduced with a retroviral vector carrying a herpes simplex virus thymidine kinase gene mutant. Hum Gene Ther. 2000;11:1569–1576.

    Article  CAS  PubMed  Google Scholar 

  36. Chen CY, Chang YN, Ryan P, et al. Effect of herpes simplex virus thymidine kinase expression levels on ganciclovir-mediated cytotoxicity and the “bystander effect”. Hum Gene Ther. 1995;6:1467–1476.

    Article  CAS  PubMed  Google Scholar 

  37. Chen SH, Kosai K, Xu B, et al. Combination suicide and cytokine gene therapy for hepatic metastases of colon carcinoma: sustained anti-tumor immunity prolongs animal survival. Cancer Res. 1996;15:3758–3762.

    Google Scholar 

  38. Freund CT, Sutton MA, Dong T, et al. Adenovirus-mediated combination suicide and cytokine gene therapy for bladder cancer. Anticancer Res. 2000;20:1359–1365.

    CAS  PubMed  Google Scholar 

  39. Toda M, Martuza RI, Rabkin SD . Combination suicide/cytokine gene therapy as adjuvants to a defective herpes simplex virus–based cancer vaccine. Gene Ther. 2001;8:332–339.

    Article  CAS  PubMed  Google Scholar 

  40. Mesnil M, Yamasaki H . Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication. Cancer Res. 2000;60:3989–3999.

    CAS  PubMed  Google Scholar 

  41. Wei MX, Bougnoux P, Sacre-salem B, et al. Suicide gene therapy of chemically induce mammary tumor in rat: efficacy and distant bystander effect. Cancer Res. 1998;58:3529–3532.

    CAS  PubMed  Google Scholar 

  42. Engelmann C, Heslan JM, Fabre M, et al. Importance mechanisms and limitations of the distant bystander effect in cancer gene therapy of experimental liver tumors. Cancer Lett. 2002;179:59–69.

    Article  CAS  PubMed  Google Scholar 

  43. Suan J, Michael A . The clinical problem and immuno-modulation. In: Habib NA, ed Cancer Gene Therapy: Past Achievements and Future Challenges. 1st ed. New York: Kluwer Academic Publishing/Plenum; 1999:292–293.

    Google Scholar 

  44. Liau LM, Black KL, Prins RM, et al. Treatment of intracranial gliomas with bone marrow–derived dendritic cells pulsed with tumor antigens. J Neurosurg. 1999;90:1115–1124.

    Article  CAS  PubMed  Google Scholar 

  45. Nouri-Shirazi M, Banchereau J, Bell D, et al. Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responses. J Immunol. 2000;165:3797–3803.

    Article  CAS  PubMed  Google Scholar 

  46. Braun SE, Chen K, Balzar BR, et al. Flt3 ligand antitumor activity in a murine breast cancer model: a comparison with granulocyte–macrophage colony-stimulating factor and a potential mechanism of action. Hum Gene Ther. 1999;10:2141–2151.

    Article  CAS  PubMed  Google Scholar 

  47. Von Eckardstein KL, Patt S, Zhu J, et al. Short-term neuropathological aspects of in vivo suicide gene transfer to the F98 rat glioblastoma using liposomal and viral vectors. Histol Histopathol. 2001;16:735–744.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cell Biology, Vontz Center for Molecular Studies, University of Cincinnati, Cincinnati, 45267-0521, Ohio, USA

    Jian Dong, Robert J Bohinski & Peter J Stambrook

  2. Department of Otolaryngology, University of Cincinnati, Cincinnati, 45267, Ohio, USA

    Ya-Qin Li & Lyon Gleich

  3. NIDCD Building 10, Room 5D55, Rockville, 20892, Maryland, USA

    Carter Van Waes

  4. Division of Medical Oncology, University of Louisville School of Medicine, Louisville, 40292, Kentucky, USA

    Fred Hendler

Authors
  1. Jian Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert J Bohinski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ya-Qin Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Carter Van Waes
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fred Hendler
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lyon Gleich
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Peter J Stambrook
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter J Stambrook.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dong, J., Bohinski, R., Li, YQ. et al. Antitumor effect of secreted Flt3-ligand can act at distant tumor sites in a murine model of head and neck cancer. Cancer Gene Ther 10, 96–104 (2003). https://doi.org/10.1038/sj.cgt.7700534

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.cgt.7700534

Keywords

This article is cited by

Search

Advanced search

Quick links